Literature DB >> 3604987

Vasculitis in primary Sjögren's syndrome. Histologic classification and clinical presentation.

M Tsokos, S A Lazarou, H M Moutsopoulos.   

Abstract

Nine out of 70 patients with primary Sjögren's syndrome had vasculitis of small and/or medium-sized vessels. The small vessel vasculitis was of the hypersensitivity type: leukocytoclastic and lymphocytic. The medium vessel vasculitis was acute necrotizing and simulated polyarteritis nodosa histologically but lacked the characteristic aneurysmal formation. A healing stage of vasculitis, presenting as endarteritis obliterans, was seen in patients with Sjögren's syndrome and a long-standing history of vasculitis. The hypersensitivity vasculitis was localized mainly in the skin and provided mild clinical symptoms. The polyarteritis nodosa-like vasculitis was localized predominantly in internal organs and was associated with life-threatening symptoms. Endarteritis obliterans was mainly seen in acral sites of the extremities and presented with recurrent symptoms of obstruction. One patient died of vasculitis. The remaining patients are alive. The presence of anemia, cryoglobulinemia, and hypocomplementemia suggested an immune-complex origin of the vasculitic process.

Entities:  

Mesh:

Year:  1987        PMID: 3604987     DOI: 10.1093/ajcp/88.1.26

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis.

Authors:  Satoshi Hayakawa; Kimimasa Nakabayashi; Miho Karube; Yoshihiro Arimura; Yoshiro Arimura; Akinori Soejima; Akira Yamada; Yasunori Fujioka
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.801

2.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 3.  Sjögren syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  CMAJ       Date:  2014-02-24       Impact factor: 8.262

Review 4.  Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Authors:  Andreas V Goules; Athanasios G Tzioufas
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 5.  Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

Review 6.  Vasculitis in Sjögren's Syndrome.

Authors:  R Hal Scofield
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 7.  [Vasculopathy in Sjögren's syndrome].

Authors:  E Feist; K-G A Hermann; A Dankof
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

8.  Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome.

Authors:  H M Markusse; M Schoonbrood; M Oudkerk; S C Henzen-Logmans
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

9.  Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome.

Authors:  Barbara Segal; William Thomas; Tyson Rogers; Joanlise M Leon; Pamela Hughes; Danielle Patel; Ketan Patel; Jill Novitzke; Michael Rohrer; Rajaram Gopalakrishnan; Sandra Myers; Abu Nazmul-Hossain; Eshrat Emamian; Andrew Huang; Nelson Rhodus; Kathy Moser
Journal:  Arthritis Rheum       Date:  2008-12-15

10.  Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.

Authors:  Saugar Maripuri; Joseph P Grande; Thomas G Osborn; Fernando C Fervenza; Eric L Matteson; James V Donadio; Marie C Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.